共 264 条
[91]
Abdellatif M(2010)Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial Mol Ther 18 643-20
[92]
Liu MM(2006)Safety and efficacy of gene transfer for Leber’s congenital amaurosis Hum Gene Ther 17 167-500
[93]
Tuo J(2010)Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration Mol Ther 18 1885-D158
[94]
Chan CC(2010)Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial Am J Ophthalmol 150 33-2630
[95]
Conley SM(2006)Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma Nat Chem Biol 2 711-2502
[96]
Cai X(2011)RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027 Curr Drug Targets 12 173-15756
[97]
Naash MI(2005)RNAi therapeutics: a potential new class of pharmaceutical drugs Cell 120 15-395
[98]
Chalberg TW(2005)Anti-VEGF compounds in the treatment of neovascular age related macular degeneration Nat Genet 37 495-369
[99]
Genise HL(2008)Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Nucleic Acids Res 36 D154-357
[100]
Vollrath D(2011)Combinatorial microRNA target predictions J Virol 85 2620-358